Similar articles

• Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.

  Hague W, Forder P, Simes J, Hunt D, Tonkin A; LIPID Investigators. Hague W, et al. Am Heart J. 2003 Apr;145(4):643-51. doi: 10.1067/mhj.2003.1. Am Heart J. 2003. PMID: 12679760 Clinical Trial.
• Lovastatin to prevent acute coronary events with average cholesterol levels.

  MacFarlane LL, Carek PJ. MacFarlane LL, et al. J Fam Pract. 1998 Aug;47(2):91-2. J Fam Pract. 1998. PMID: 9722787 No abstract available.
• [CARE[ Cholesterol and Recurrent Events Trial]].

  Oida K. Oida K. Nihon Rinsho. 2001 Mar;59 Suppl 3:427-32. Nihon Rinsho. 2001. PMID: 11347108 Review. Japanese. No abstract available.
• Cholesterol reduction and coronary prevention.

  Prabhakaran D. Prabhakaran D. Natl Med J India. 1997 Jan-Feb;10(1):24-5. Natl Med J India. 1997. PMID: 9069704 No abstract available.
• [LIPID study [Long-term Intervention with Pravastatin in Ischaemic Disease study]].

  Homma Y. Homma Y. Nihon Rinsho. 2001 Mar;59 Suppl 3:416-21. Nihon Rinsho. 2001. PMID: 11347106 Review. Japanese. No abstract available.